Innate Pharma SA
PAR:IPH
Innate Pharma SA
PAR:IPH
Price:
1.104
EUR
-4.99%
Market Cap:
€103.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Innate Pharma SA
PAR:IPH
|
FR |
|
F
|
Fom Technologies A/S
CSE:FOM
|
DK |
|
Shinva Medical Instrument Co Ltd
SSE:600587
|
CN |
|
S
|
Sai Gon Thuong Tin Real Estate JSC
VN:SCR
|
VN |
|
Chobi Co Ltd
KRX:001550
|
KR |
|
Nam.R SA
PAR:ALNMR
|
FR |
|
O
|
Oishi Group PCL
SET:OISHI
|
TH |
|
Dream Industrial Real Estate Investment Trust
TSX:DIR.UN
|
CA |
|
MRV Engenharia e Participacoes SA
BOVESPA:MRVE3
|
BR |
|
Ninestar Corp
SZSE:002180
|
CN |
|
Match Group Inc
NASDAQ:MTCH
|
US |
|
Gujarat Raffia Industries Ltd
NSE:GUJRAFFIA
|
IN |
|
P
|
Pantoro Ltd
ASX:PNR
|
AU |
|
Crocs Inc
NASDAQ:CROX
|
US |
|
A
|
Apotea AB (publ)
STO:APOTEA
|
SE |
|
Pavlovskiy Avtobus PAO
MOEX:PAZA
|
RU |
|
W
|
Wisdom Sports Group
HKEX:1661
|
CN |
|
Ufuk Yatirim Yonetim ve Gayrimenkul AS
IST:UFUK.E
|
TR |
|
Hyliion Holdings Corp
NYSE:HYLN
|
US |
|
E
|
Empyrean Technology Co Ltd
SZSE:301269
|
CN |
|
P
|
Platzer Fastigheter Holding AB (publ)
STO:PLAZ B
|
SE |
Income Statement
Earnings Waterfall
Innate Pharma SA
Innate Pharma SA
Income Statement
Innate Pharma SA
Innate Pharma SA
Currency: EUR
| Dec-2006 | Jun-2007 | Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Revenue |
6
N/A
|
8
+27%
|
9
+10%
|
10
+10%
|
7
-22%
|
6
-24%
|
3
-42%
|
1
-74%
|
0
-76%
|
1
+376%
|
7
+645%
|
12
+59%
|
10
-12%
|
10
-8%
|
12
+31%
|
9
-28%
|
1
-90%
|
1
+30%
|
18
+1 417%
|
33
+86%
|
56
+69%
|
55
-2%
|
33
-41%
|
33
+2%
|
80
+140%
|
115
+43%
|
69
-40%
|
47
-32%
|
56
+19%
|
35
-38%
|
12
-65%
|
45
+272%
|
50
+10%
|
44
-12%
|
52
+19%
|
25
-52%
|
13
-49%
|
6
-52%
|
3
-54%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(10)
|
(13)
|
(16)
|
(16)
|
(15)
|
(17)
|
(13)
|
(12)
|
(10)
|
(10)
|
(11)
|
(13)
|
(9)
|
(9)
|
(10)
|
(13)
|
(10)
|
(9)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
|
| Gross Profit |
(4)
N/A
|
(5)
-27%
|
(7)
-44%
|
(6)
+12%
|
(8)
-27%
|
(12)
-49%
|
(10)
+14%
|
(11)
-7%
|
(10)
+5%
|
(9)
+12%
|
(4)
+56%
|
(1)
+83%
|
1
N/A
|
1
-24%
|
3
+287%
|
(4)
N/A
|
3
N/A
|
(8)
N/A
|
15
N/A
|
30
+98%
|
53
+76%
|
52
-3%
|
28
-45%
|
29
+2%
|
76
+162%
|
111
+46%
|
66
-41%
|
44
-33%
|
53
+20%
|
31
-42%
|
9
-71%
|
42
+367%
|
46
+9%
|
41
-12%
|
49
+21%
|
22
-55%
|
10
-56%
|
3
-69%
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(4)
|
(3)
|
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(11)
|
(14)
|
(26)
|
(33)
|
(46)
|
(60)
|
(68)
|
(66)
|
(71)
|
(81)
|
(93)
|
(89)
|
(51)
|
(40)
|
(57)
|
(56)
|
(62)
|
(107)
|
(62)
|
(60)
|
(61)
|
(54)
|
(57)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(7)
|
(8)
|
(8)
|
(9)
|
(9)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(9)
|
(8)
|
(10)
|
(8)
|
(6)
|
(7)
|
(9)
|
(14)
|
(16)
|
(14)
|
(16)
|
(21)
|
(24)
|
(29)
|
(18)
|
(15)
|
(23)
|
(16)
|
(20)
|
(18)
|
(17)
|
(17)
|
(18)
|
(19)
|
(19)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(11)
|
(24)
|
(31)
|
(42)
|
(53)
|
(58)
|
(59)
|
(59)
|
(58)
|
(60)
|
(55)
|
(38)
|
(34)
|
(41)
|
(44)
|
(45)
|
(53)
|
(49)
|
(47)
|
(48)
|
(40)
|
(44)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(7)
|
(12)
|
(17)
|
(16)
|
(9)
|
(5)
|
(5)
|
(4)
|
(4)
|
(6)
|
(5)
|
(3)
|
(2)
|
(2)
|
0
|
|
| Other Operating Expenses |
2
|
4
|
5
|
6
|
5
|
5
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
(0)
|
7
|
7
|
7
|
9
|
11
|
10
|
11
|
12
|
10
|
8
|
12
|
13
|
14
|
12
|
8
|
8
|
(30)
|
10
|
6
|
7
|
7
|
6
|
|
| Operating Income |
(7)
N/A
|
(8)
-10%
|
(9)
-14%
|
(9)
0%
|
(11)
-21%
|
(16)
-45%
|
(16)
+2%
|
(14)
+8%
|
(14)
+4%
|
(13)
+7%
|
(8)
+40%
|
(4)
+47%
|
(3)
+16%
|
(3)
+1%
|
(3)
+17%
|
(10)
-247%
|
(20)
-106%
|
(22)
-9%
|
(11)
+50%
|
(3)
+73%
|
8
N/A
|
(8)
N/A
|
(40)
-417%
|
(37)
+8%
|
5
N/A
|
30
+490%
|
(27)
N/A
|
(45)
-66%
|
1
N/A
|
(10)
N/A
|
(48)
-391%
|
(14)
+71%
|
(16)
-18%
|
(66)
-304%
|
(13)
+81%
|
(39)
-205%
|
(52)
-34%
|
(51)
+2%
|
(54)
-7%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
1
|
0
|
0
|
1
|
1
|
(1)
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
(0)
|
(0)
|
0
|
0
|
3
|
4
|
0
|
5
|
(0)
|
(8)
|
(2)
|
(2)
|
0
|
2
|
1
|
(1)
|
(1)
|
1
|
1
|
1
|
2
|
3
|
2
|
0
|
4
|
5
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(41)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
1
|
0
|
(0)
|
0
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
(0)
|
(2)
|
(0)
|
2
|
4
|
(1)
|
(1)
|
3
|
1
|
(2)
|
(2)
|
2
|
2
|
2
|
2
|
1
|
0
|
|
| Pre-Tax Income |
(6)
N/A
|
(7)
-17%
|
(9)
-26%
|
(8)
+5%
|
(10)
-17%
|
(16)
-57%
|
(15)
+6%
|
(13)
+8%
|
(14)
-2%
|
(12)
+11%
|
(7)
+43%
|
(4)
+46%
|
(3)
+15%
|
(4)
-9%
|
(3)
+17%
|
(10)
-233%
|
(20)
-104%
|
(19)
+5%
|
(7)
+64%
|
(2)
+72%
|
13
N/A
|
(7)
N/A
|
(48)
-562%
|
(40)
+16%
|
3
N/A
|
32
+1 095%
|
(21)
N/A
|
(44)
-114%
|
(1)
+98%
|
(8)
-860%
|
(45)
-471%
|
(15)
+66%
|
(58)
-277%
|
(63)
-8%
|
(8)
+88%
|
(34)
-350%
|
(49)
-45%
|
(46)
+7%
|
(49)
-7%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(6)
|
(7)
|
(9)
|
(8)
|
(10)
|
(16)
|
(15)
|
(13)
|
(14)
|
(12)
|
(7)
|
(4)
|
(3)
|
(4)
|
(3)
|
(10)
|
(20)
|
(19)
|
(7)
|
(2)
|
13
|
(8)
|
(48)
|
(40)
|
3
|
32
|
(21)
|
(44)
|
(1)
|
(8)
|
(45)
|
(15)
|
(58)
|
(63)
|
(8)
|
(34)
|
(49)
|
(46)
|
(49)
|
|
| Net Income (Common) |
(6)
N/A
|
(7)
-17%
|
(9)
-26%
|
(8)
+5%
|
(10)
-17%
|
(16)
-57%
|
(15)
+6%
|
(13)
+8%
|
(14)
-2%
|
(12)
+11%
|
(7)
+43%
|
(4)
+46%
|
(3)
+15%
|
(4)
-9%
|
(3)
+17%
|
(10)
-233%
|
(20)
-104%
|
(19)
+5%
|
(7)
+64%
|
(2)
+72%
|
13
N/A
|
(8)
N/A
|
(48)
-541%
|
(40)
+17%
|
3
N/A
|
32
+965%
|
(21)
N/A
|
(44)
-114%
|
(64)
-44%
|
(24)
+63%
|
(53)
-123%
|
(23)
+57%
|
(58)
-155%
|
(63)
-8%
|
(8)
+88%
|
(34)
-350%
|
(49)
-45%
|
(46)
+7%
|
(49)
-7%
|
|
| EPS (Diluted) |
-0.34
N/A
|
-0.28
+18%
|
-0.36
-29%
|
-0.33
+8%
|
-0.38
-15%
|
-0.6
-58%
|
-0.56
+7%
|
-0.36
+36%
|
-0.36
N/A
|
-0.32
+11%
|
-0.19
+41%
|
-0.1
+47%
|
-0.08
+20%
|
-0.09
-12%
|
-0.07
+22%
|
-0.2
-186%
|
-0.39
-95%
|
-0.35
+10%
|
-0.13
+63%
|
-0.04
+69%
|
0.23
N/A
|
-0.14
N/A
|
-0.89
-536%
|
-0.69
+22%
|
0.05
N/A
|
0.53
+960%
|
-0.31
N/A
|
-0.56
-81%
|
-0.81
-45%
|
-0.3
+63%
|
-0.66
-120%
|
-0.28
+58%
|
-0.73
-161%
|
-0.79
-8%
|
-0.09
+89%
|
-0.42
-367%
|
-0.61
-45%
|
-0.55
+10%
|
-0.55
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
